Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015:2015:589471.
doi: 10.1155/2015/589471. Epub 2015 Aug 5.

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children

Linda Petrone  1 , Angela Cannas  1 , Francesco Aloi  2 , Martin Nsubuga  3 , Joseph Sserumkuma  3 , Ritah Angella Nazziwa  3 , Levan Jugheli  4 , Tedson Lukindo  5 , Enrico Girardi  6 , Klaus Reither  4 , Delia Goletti  1
Affiliations
Clinical Trial

Blood or Urine IP-10 Cannot Discriminate between Active Tuberculosis and Respiratory Diseases Different from Tuberculosis in Children

Linda Petrone et al. Biomed Res Int. 2015.

Abstract

Objectives: Interferon-γ inducible protein 10 (IP-10), either in blood or in urine, has been proposed as a tuberculosis (TB) biomarker for adults. This study aims to evaluate the potential of IP-10 diagnostics in children from Uganda, a high TB-endemic country.

Methods: IP-10 was measured in the blood and urine concomitantly taken from children who were prospectively enrolled with suspected active TB, with or without HIV infection. Clinical/microbiological parameters and commercially available TB-immune assays (tuberculin skin test (TST) and QuantiFERON TB-Gold In-Tube (QFT-IT)) were concomitantly evaluated.

Results: One hundred twenty-eight children were prospectively enrolled. The analysis was performed on 111 children: 80 (72%) of them were HIV-uninfected and 31 (27.9%) were HIV-infected. Thirty-three healthy adult donors (HAD) were included as controls. The data showed that IP-10 is detectable in the urine and blood of children with active TB, independent of HIV status and age. However, although IP-10 levels were higher in active TB children compared to HAD, the accuracy of identifying "active TB" was low and similar to the TST and QFT-IT.

Conclusion: IP-10 levels are higher in children with respiratory illness compared to controls, independent of "TB status" suggesting that the evaluation of this parameter can be used as an inflammatory marker more than a TB test.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of the study participants evaluated.
Figure 2
Figure 2
Blood and urine IP-10 levels are significantly increased in children with “active TB” compared to healthy adult donors (HAD). (a-b) Blood IP-10 levels were significantly increased in the children with a diagnosis of “active TB” and “respiratory diseases” compared to HAD, independent of HIV status. (c-d) Urine IP-10 levels were increased in the children diagnosed with “active TB” compared to the other two groups (HAD and “respiratory diseases”). IP-10 ELISA was performed in plasma and urine, and urine IP-10 was normalized with the creatinuria levels. The horizontal lines represent the median; statistical analysis was performed using the Mann-Whitney test with Bonferroni correction and p value was considered significant if <0.016. IP-10: IFN-γ inducible protein 10; HAD: healthy adult donors; TB: tuberculosis; HIV: Human Immunodeficiency Virus.
Figure 3
Figure 3
Blood and urine IP-10 do not correlate with age in children. (a) Spearman rank correlation (r s) of blood IP-10 and age of children (p = 0.1, r s = −0.1). (b) Spearman rank correlation (r s) of urine IP-10 and age in children (p = 0.8, r s = −0.01). ELISA was performed in blood or urine and urine IP-10 was normalized with the creatinuria levels. Statistical analysis was performed using the Spearman rank correlation test and p value was considered significant if <0.05. IP-10: IFN-γ inducible protein 10.
See this image and copyright information in PMC

References

    1. WHO. Global tuberculosis report 2014. WHO Global TB Report 2014. 2014
    1. Portevin D., Moukambi F., Clowes P., et al. Assessment of the novel T-cell activation marker-tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. The Lancet Infectious Diseases. 2014;14(10):931–938. doi: 10.1016/s1473-3099(14)70884-9. - DOI - PubMed
    1. Zar H. J., Connell T. G., Nicol M. Diagnosis of pulmonary tuberculosis in children: new advances. Expert Review of Anti-Infective Therapy. 2010;8(3):277–288. doi: 10.1586/eri.10.9. - DOI - PubMed
    1. Cuevas L. E., Browning R., Bossuyt P., et al. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. The Journal of Infectious Diseases. 2012;205(supplement 2):S209–S215. doi: 10.1093/infdis/jir879. - DOI - PMC - PubMed
    1. Berti E., Galli L., Venturini E., de Martini M., Chiappini E. Tuberculosis in childhood: a systematic review of national and international guidelines. BMC Infectious Diseases. 2014;14(supplement 1, article S3) - PMC - PubMed

Publication types

LinkOut - more resources